AKT1 and metastatic malignant neoplasm: Nevertheless, these studies analyze the inhibition of AKT in patients with metastatic cancer in general but do not distinguish between the efficacy of AKT inhibitors in patients with bone metastases compared to patients with non-bone metastases.